The influence on human osteoblasts in vitro on non-steroidal anti-inflammatory drugs which act on different cyclooxygenase enzymes

Journal of Bone and Joint Surgery - Series B

Volumn 86, Issue 3, 2004, Pages 444-449

  Evans, C E ^a   Butcher, C ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 (3 FLUOROPHENYL) 5,5 DIMETHYL 4 (4 METHYLSULFONYLPHENYL) 2(5H) FURANONE; ALKALINE PHOSPHATASE; COLLAGEN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DNA; INDOMETACIN; NITRIC OXIDE DONOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; THROMBOXANE;

ARTICLE; BONE DISEASE; CELL ADHESION; CELL COUNT; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DNA SYNTHESIS; DOSE RESPONSE; DRUG MECHANISM; DRUG SAFETY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; OSTEOBLAST; PATIENT CARE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS;

ACETAMINOPHEN; ALKALINE PHOSPHATASE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CELL COUNT; CELLS, CULTURED; COLLAGEN; CYCLOOXYGENASE INHIBITORS; DNA; FLURBIPROFEN; FURANS; HUMANS; INDOMETHACIN; NITRATES; NITRIC OXIDE; NITRIC OXIDE DONORS; OSTEOBLASTS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 2342437484     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.86B3.14592     Document Type: Article

References (44)

1. Kawaguchi H, Pilbeam CC, Harrison JR, Raisz LG. The role of prostaglandins in the regulation of bone metabolism. Clin Orthop 1995;313:34-46.
2. Raisz LG, Pilbeam CC, Fall PM. Prostaglandins: mechanism of action and regulation of production in bone. Osteoporosis Int 1993; 3 (Suppl 1): 136-40.
3. Westacott CI, Taylor G, Atkins R, Elson C. Interleukin 1 alpha and beta production by cells isolated from membranes around aseptically loose joint replacements. Ann Rheum Dis 1992;51:638-42.
4. Ho ML, Chang LY, Chuang LY, Hsu HK, Wang GJ. Effects of nonsteroidal anti-inflammatory drugs and prostaglandins on osteoblastic functions. Biochem Pharmacol 1999;58:983-90.
5. Nemoto K, Bernecker PM, Pilbeam CC, Raisz LG. Expression and regulation of prostaglandin F receptor MRNA in rodent osteoblastic cells. Prostaglandins 1995;50: 349-58.
6. Eujimori A, Tsutsumi M, Fukase M, Fujita T. Cyclooxygenase inhibitors enhance cell growth in an osteoblastic cell line, MC3T3-E1. J Bone Miner Res 1989;4:697-704.
7. Pilbeam CC, Raisz LG, Voznesenasky O, et al. Autoregulation of inducible prostaglandin G/H synthase in osteoblastic cells by prostaglandins. J Bone Miner Res 1995;10:406-14.
8. Tjandrinawata RR, Dahiya R, Hughes-Fulford M. Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells. Br J Cancer 1997; 75: 1111-8.
9. Chandrasekharan NVm Dai H, Roos T, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure and expression. Proc Natl Acad Sci USA 2002;99:13926-31.
10. Vane JR, Botting RM. Mechanism of action of antiinflammatory drugs. Int J Tissue React 1998;20:3-15.
11. Yuan CJ, Mandal AK, Zhang Z, Mukherjee AB. Transcriptional regulation of cyclooxygenase-2 gene expression: novel effects of nonsteroidal anti-inflammatory drugs. Cancer Res 2000;60:1084-91.
12. Dewitt DL. Cox-2 selective inhibitors: the new super aspirins. Mol Pharmacol 1999; 55:625-31.
13. Riendeau D, Percival MO, Boyce S, et al. Biochemical and pharmacological profile of tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol 1997;1212:105-17.
14. Sengupta S. Cyclooxygenase-2: a new therapeutic agent. Indian J Pharmacol 1999; 31:322-32.
15. Watson AJM. Chemopreventative effects of NSAIDs against colorectal cancer: regulation of apoptosis and mitosis by COX-1 and COX-2. Histol Histopathol 1998;13: 591-7.
16. Keeble JE, Moore PK. Pharmacology and portential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs. Br J Pharmacol 2002;137:295-310.
17. Fiorucci S, Antonelli E, Burgaud JL, Morelli A. Nitric oxide-releasing NSAIDs: a review of their current status. Drug Saf 2001;24:801-11.
18. Armour KJ, van t'Hof RJ, Armour KE, et al. Inhibition of bone resorption in vitro and prevention of ovariectomy-induced bone loss in vivo by Flurbiprofen nitroxybutylester. Arthritis Rheum 2001;44:2185-92.
19. van t'Hof RJ, Ralston SH. Nitric oxide and bone. Immunology 2001;103:255-61.
20. Allen HL, Wase A, Bear WT. Indomethacin and aspirin: effect of nonsteroidal anti-inflammatory agents on the rate of fracture repair in the rat. Acta Orthop Scand 1980;51:595-600.
21. Muscara MN, McKnight W, Asfaha S, Wallace JL. Wound collagen deposition in rats: effects of a NO-NSAID and a selective COX-2 inhibitor. Br J Pharmacol 2000; 129:681-6.
22. Altman RD, Latta LL, Keer R, et al. Effects of non-steroidal anti-inflammatory drugs on fracture healing: a laboratory study in rats. J Orthop Trauma 1995;9:392-400.
23. Lindholm TS, Tornkvist H. Inhibitory effect on bone formation and calcification exerted by the anti-inflammatory drug Ibuprofen: an experimental study on adult rat with fracture. Scand J Rheumatol 1981;10:38-42.
24. Tornkvist H, Lindholm TS. Effect of ibuprofen on mass and composition of fracture callus and bone: an experimental study on adult rats. Scand J Rheumatol 1980; 9: 167-71.
25. Butcher CK, Marsh DR. The effects of non-steroidal anti-inflammatory drugs on the rate of tibial fracture union. Injury 1996;27:375.
26. Giannoudis PV, MacDonald BA, Matthews SJ, et al. Nonunion of the femoral diaphysis: the influence of reaming and non-steroidal anti-inflammatory drugs. J Bone Joint Surg [Br] 2000;82-B:655-8.
27. van Staa TT, Leufkens HG, Cooper C. Use of nonsteroidal anti-inflammatory drugs and risk of fractures. Bone 2000;27:563-8.
28. Keller JC, Trancik TM, Young FA, St Mary E. Effects of indomethacin on bone ingrowth. J Orthop Res 1989;7:28-34.
29. 3H]thymidine incorporation by human osteoblasts. Br J Rheumatol 1988;27:291-4.
30. Siggelkow H, Rebenstorff K, Kurre W, et al. Development of the osteoblast phenotype in primary human osteoblasts in culture: comparison with rat calvarial cells in osteoblast differentiation. J Cell Biochem 1999;75:22-35.
31. Stein GS, Lian JB, Owen TA. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J 1990;4:3111-23.
32. 324,25(OH)2D3, parathyroid hormone, and glucocorticoids. Metab Bone Dis Relat Res 1984;5:229-34.
33. Evans CE, Galasko CSB, Ward C. In vitro proliferation of cells cultured from human cancellous bone. In: Ali SY, ed. Cell mediated calcification and matrix vesicles. Amsterdam: Elsevier Science Publishers BNV (Biomedical Division) 1986:303-8.
34. Evans CE, Galasko CSB, Ward C. Effect of donor age on the growth in vitro of cells obtained from human trabecular bone. J Orthop Res 1990;8:234-7.
35. Mosmann T. Rapid, colourimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Methods 1983;65:55-63.
36. Puzas JE, Drivdahl RH, Howard GA, Baylink DJ. Endogenous inhibitor of bone cell proliferation. Proc Soc Exp Biol Med 1981;166:113-22.
37. Lowry OH, Roberts NR, Wu M-L, Hixon HS, Crawford EJ. The quantitative histochemistry of brain. II enzyme measurements. J Biol Chem 1954;207:18-37.
38. Guez D, Lesclous P, Beroukh B, Saffar JL. Impact of the timing of opmethacin treatment in a model of synchronized bone remodelling in rats. Exp Physiol 2001;86:373-9.
39. Lerner U. Indomethacin inhibits bone resorption in vitro without affecting bone collagen synthesis. Agents Actions 1982;12:466-70.
40. Sudmann E, Dregelid E, Bessesen A, Morland J. Inhibition of fracture healing by Indomethacin in rats. Eur J Clin Invest 1979;9:333-9.
41. Kanematsu M, Ikeda K, Yamada Y. Interaction between nitric oxide synthesis and cyclooxygenase pathways in ostooblastic MC3T3-E1 cells. J Bone Min Res 1997;12: 1789-96.
42. Sude M, Tanaka K, Sakuma Y, et al. Prostaglandin E(2) (PGE(2)) induces the c-fos and c-jun expressions via the EP(1) subtype of PGE receptor in mouse osteoblastic MC3T3-E1 cells. Calcif Tissue Int 2000;66:217-33.
43. Zhang X, Schwarz EM, Young DA, et al. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 2002;109:1405-15.
44. Fiorucci S, Santucci L, Gresele P. et al. Gastrointestinal safety of NO-Aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study. Gastroenterology 2003;124:600-7.